Ypsomed Holding AG (LON:0QLQ)

Market Cap	3.85B -6.2%
Revenue (ttm)	734.77M +27.6%
Net Income	181.00M +160.8%
EPS	13.26 +160.7%
Shares Out	n/a
PE Ratio	21.27
Forward PE	23.42
Dividend	2.03 (0.72%)
Ex-Dividend Date	Jul 4, 2025

Volume	3,394
Average Volume	1,632
Open	301.40
Previous Close	297.60
Day's Range	296.00 - 302.20
52-Week Range	263.50 - 440.00
Beta	0.74
RSI	59.62
Earnings Date	May 20, 2026

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 2,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLQ

Financial Performance

In fiscal year 2025, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.

Financial numbers in CHF